PRospective Evaluation of interventional StudiEs on boNe meTastases

Recruiting

• Conditions: Bone metastases; metastatic bone disease; 10005959; 10027476

• Registration Number: NL-OMON53152
• Lead Sponsor: niversitair Medisch Centrum Utrecht

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 18 June 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 11000

Inclusion Criteria

Histologic proof of malignancy;
Radiographic or histologic proof of metastatic bone disease;
Referred to the Department of Radiotherapy or Orthopedic Surgery;
18 years and older;
Informed consent - at least - for use of routinely collected clinical data.

Exclusion Criteria

Mentally incompetent patients;
Life expectancy of less than a week indicated by the treating physician.

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Clinical parameters (co-morbidity, oncological history, symptoms, imaging,<br /><br>technical and treatment data), clinical endpoints (pain response, toxicity and<br /><br>survival) and patient reported outcomes (pain scores and QoL).</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Not applicable.</p><br>